English
简体中文
Total: £ 56.28
2026-03-02 | Pages: 108 | Tables: 106
The global Investigational New Drug CDMO market was valued at US$ 5306 million in 2025 and is anticipated to reach US$ 8196 million by 2032, at a CAGR of 6.5% from 2026 to 2032.Investigational New Drug CDMO refers to a Contract Development and Manufa...
2026-03-02 | Pages: 124 | Tables: 125
The global Chinese Patent Medicine for Bones and Muscles market was valued at US$ 3202 million in 2025 and is anticipated to reach US$ 4520 million by 2032, at a CAGR of 5.1% from 2026 to 2032.Chinese patent medicine are herbal medicines in Tradition...
2026-03-02 | Pages: 121 | Tables: 121
The global Chlorogenic Acid API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape....
2026-03-02 | Pages: 120 | Tables: 111
The global Modified Oligo Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Modified Oligo Service is a professional service that provides researchers with the ability to...
2026-03-02 | Pages: 114 | Tables: 115
The global siRNA/miRNA Synthesis Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.siRNA/miRNA Synthesis Service is a professional service that provides small interfering...
2026-03-02 | Pages: 103 | Tables: 104
The global Udder Health for Dairy Cows market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.This report mainly focuses on udder health for dairy cows market. Udder health refers to ...
2026-03-02 | Pages: 106 | Tables: 101
The global Veterinary Surgical Procedures market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.This report mainly focuses on veterinary surgical procedures market. Veterinary surgic...
2026-03-02 | Pages: 108 | Tables: 104
The global High-throughput Multi-gene Level Regulation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.High-throughput multi-gene level regulation is a modern biotechnology tha...
2026-03-02 | Pages: 115 | Tables: 118
The global Clinical and Non-clinical Contract Research Organization Services market was valued at US$ 89710 million in 2025 and is anticipated to reach US$ 163880 million by 2032, at a CAGR of 9.1% from 2026 to 2032.Clinical and Non-Clinical Contract...
2026-03-02 | Pages: 105 | Tables: 106
The global Breast Adenocarcinoma Treatment market was valued at US$ 24820 million in 2025 and is anticipated to reach US$ 46440 million by 2032, at a CAGR of 9.5% from 2026 to 2032.Breast adenocarcinoma is a type of breast cancer that originates in t...
2026-03-02 | Pages: 101 | Tables: 106
The global Children's Drug Resistance Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Children's drug resistance testing is a test of the sensitivity of pathogens (such...
2026-03-02 | Pages: 106 | Tables: 102
The global Metastatic Lung Adenocarcinoma Treatment market was valued at US$ 5101 million in 2025 and is anticipated to reach US$ 10230 million by 2032, at a CAGR of 10.6% from 2026 to 2032.Metastatic lung adenocarcinoma treatment focuses on managing...
2026-03-02 | Pages: 107 | Tables: 102
The global Blastic Plasmacytoid Dendritic Cell Neoplasm market was valued at US$ 156 million in 2025 and is anticipated to reach US$ 257 million by 2032, at a CAGR of 7.5% from 2026 to 2032.This growth is attributed to the rising global incidence of ...
2026-03-02 | Pages: 116 | Tables: 117
The global Mouse Model for Drug Screening and Evaluation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the g...
2026-03-02 | Pages: 111 | Tables: 113
The global Plasma Therapy market was valued at US$ 357 million in 2025 and is anticipated to reach US$ 690 million by 2032, at a CAGR of 10.0% from 2026 to 2032.Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to o...
